Metal-Containing Molecules and Nanomaterials
From Diagnosis to Therapy
Series: Metal Ions in Life Sciences Series;
- Publisher's listprice GBP 49.99
-
23 882 Ft (22 745 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 2 388 Ft off)
- Discounted price 21 494 Ft (20 471 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
23 882 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 28 September 2025
- ISBN 9781032422169
- Binding Paperback
- No. of pages188 pages
- Size 229x152 mm
- Weight 350 g
- Language English
- Illustrations 36 Illustrations, black & white; 31 Illustrations, color; 2 Halftones, color; 36 Line drawings, black & white; 29 Line drawings, color; 5 Tables, black & white 699
Categories
Short description:
Since the discovery and successful deployment of salvarsan to treat syphilis, as well as cisplatin as a cancer drug, the field of metallodrugs has been flourishing.
MoreLong description:
Since the discovery and successful deployment of salvarsan to treat syphilis, as well as cisplatin as a cancer drug, the field of metallodrugs has been flourishing. In addition to therapeutic applications, metals and metal-containing molecules have properties, such as an electrochemical or an optical signal, that can be used to diagnose biologically relevant molecules or unravel cellular metabolism. Moreover, metals are part of the essential elements for life, and of increased attention in nutraceuticals. Most of the current diagnosis processes, therapeutics, and nutraceuticals are based on organic molecules. MILS-26 reviews in 7 comprehensive chapters, written by 20 experienced authors, the most recent metal-containing molecules and nanomaterials for diagnosis and therapy.
Features:
- The field of metallodrugs has been flourishing and this area of research can be used to diagnose specific biologically relevant molecules or unravel cellular metabolism.
- The authors are preeminent bioinorganic and medicinal inorganic chemists and review the most current research in this field.
- The book discusses the properties and therapeutic applications of metals and metal-containing molecules including the use of electrochemical or optical signal for diagnosis of biologically relevant molecules.
- It endorses and stimulates research in the vibrant field of biological inorganic chemistry.
- It reviews the most current research supporting the relevance of metal-containing molecules and nanomaterials for diagnosis and therapy.
More
Table of Contents:
Chapter 1 Electrochemical Sensors with Inorganic Redox Mediators
Mario A. Alpuche-Aviles
Chapter 2 Recent Advances of Medicinal Properties of Vanadium Compounds: Cancer and Other Diseases
Kateryna Kostenkova, Kameron Klugh, and Debbie C. Crans
Chapter 3 Ruthenium-Phthalocyanine Compounds as Prototypes for Photodynamic Therapy
Amanda Blanque Becceneri, Matheus Torelli Martin, Francisco Rinaldi Neto, Peter C. Ford, and Roberto Santana da Silva
Chapter 4 Metal Complexes as Probes and Inhibitors of Metabolic Enzymes
Madeline Denison, Claudia Turro, and Jeremy J. Kodanko
Chapter 5 Heme-Based Therapeutics
Elmira Alipour, Mark T. Gladwin, and Daniel B. Kim-Shapiro
Chapter 6 Metal-Containing and Metal-Associated Dietary Nutrients
Rebeca L. Fernandez, Vanessa J. Lee, and Marie C. Heffern
Chapter 7 Why is Gadolinium Still Preferred in Contrast Agents for MRI?
Mark Woods and Mauro Botta
More
